Archive for 'Tag Archives: 'UCB''
UCB and Harvard University announce new research alliance demonstrating how academia and industry team up with the interest of the patient in mind
UCB is teaming up with Harvard Medical School in an innovative collaboration for the third time in 18 months exemplifying once again how leaders in academia and industry are coupling together to advance the progress of [...]
With the opening of its new pilot biotechnology center, UCB is gearing up to reinforce its biotech activity through industry-academia research and collaboration. As one of the first plants of its kind in Belgium to produce [...]
International Drug Development Institute (IDDI, Louvain-La-Neuve, Belgium) to develop an innovative Central Statistical Monitoring (CSM) service.
Active in Europe, the United States and Asia, a company respectfully established in the fields of biostatistics, data management and central randomization, IDDI has created a new monitoring system responding to the importance and high recommendation of [...]
UCB and Amgen Initiate Sclerostin Antibody Phase 3 program in patients with postmenopausal osteoporosis
First Patient Randomized Marks Start of Phase 3 Program to Evaluate Safety and Efficacy of CDP7851/AMG 785 in Women With Postmenopausal Osteoporosis Brussels, Belgium & Thousand Oaks, Calif., (April 4, 2012) UCB (Euronext Brussels: UCB) and [...]
UCB and Harvard University will officially launch their innovative Research Alliance. The Alliance creates a unique drug discovery bridge between industry and academia, with Harvard scientists continuing their research that holds potential for the development of [...]